Volume 6, Issue 3 (7-2008)                   IJRM 2008, 6(3): 51-0 | Back to browse issues page

XML Print

Download citation:
BibTeX | RIS | EndNote | Medlars | ProCite | Reference Manager | RefWorks
Send citation to:
Aflatoonian A, Ghandi S, Tabibnejad N. Comparison of coasting with Cabergoline administration for prevention of early severe OHSS in ART cycles. IJRM 2008; 6 (3) :51-0
URL: http://ijrm.ir/article-1-112-en.html
Comparison of coasting with Cabergoline administration for prevention of early severe OHSS in ART cycles
Abbas Aflatoonian * 1, Sedigheh Ghandi2 , Nasim Tabibnejad3
1- Research and Clinical Center for Infertility, Yazd University of Medical Sciences, Yazd, Iran , aflatoonian@yazdivf.org
2- Department of Obstetrics and Gynecology, Sabzevar University of Medical Sciences, Sabzevar, Iran
3- Research and Clinical Center for Infertility, Yazd University of Medical Sciences, Yazd, Iran
Abstract:   (2751 Views)
Background: One of the major and life-threatening side effects of Assisted Reproductive Technique (ART) is ovarian hyperstimulation syndrome (OHSS). The available data however, have been showed that both Cabergoline (anti VEGF) and coasting reduce the severity of OHSS.
Objective: We aimed to compare coasting and Cabergoline administration in prevention of severe OHSS.
Materials and Methods: A total of 60 IVF/ICSI cycles were selected. Patients at risk of developing OHSS were divided into two groups as patient's convenience. For 30 patients in coasting group, exogenous gonadotropins were withheld to allow E2 to decrease while GnRH-a was maintained. Then 10,000 unit hCG was administrated and oocyte retrieval was performed 36 hours later. In Cabergoline group, 30 patients were administered with 0.5mg Cabergoline tablet on day of hCG injection, continued for 8 days.
Results: The mean number of retrieved, good quality, mature oocytes and the mean number of embryos were significantly different in two groups (p<0.05). The clinical pregnancy rate was 13.3% in coasting and 26.7% in Cabergoline group that was not significantly different (p>0.05). The incidence of severe OHSS was similar in two groups.
Conclusion: The Cabergoline was as effective as coasting in the prevention of early severe OHSS in high risk patients, but yielded more retrieved oocytes.
Keywords: Cabergoline, Coasting, OHSS, ART.
Full-Text [PDF 99 kb]   (455 Downloads) |   |   Full-Text (HTML)  (369 Views)  
Type of Study: Original Article |
References
1. Whelan J, Vlahos N. The ovarian hyperstimulation syndrome. Fertil Steril 2000; 73:883-896. [DOI:10.1016/S0015-0282(00)00491-X]
2. Roest J. Severe OHSS: An 'epidemic' caused by doctors. Hum Reprod 1999; 14: 2183. [DOI:10.1093/humrep/14.9.2183]
3. Bergh PA, Navot D. Ovarian hyperstimulation syndrome: a review of pathophysiology. J Assist Reprod Genet 1992; 9:429- 438. [DOI:10.1007/BF01204048]
4. Brinsden PR. Diagnosis, Prevention and management of OHSS. Br J Obstet Gynecol 1995; 102:767-772. [DOI:10.1111/j.1471-0528.1995.tb10840.x]
5. Waltenberger J, Claesson-Welsh L, Siegbahn A, Shibuya M, Heldin CH. Different signal transduction properties of KDR and Flt1, two receptors for vascular endothelial growth factor. J Biol Chem 1994; 26:26988-26995.
6. Verheul HM, Hoekman K, Jorna AS, Smit EF, Pinedo HM. Targeting vascular endothelial growth factor blockage: ascites and pleural effusion formation. Oncologist 2000; 5:s45-s50. [DOI:10.1634/theoncologist.5-suppl_1-45]
7. Delvigne A, Rozenberg S. Epidemiology and prevention of ovarian hyperstimulation syndrome (OHSS): a review. Hum Reprod Update 2002; 8:559 -577. [DOI:10.1093/humupd/8.6.559]
8. Egbase PE, Makhseed M, Al Sharhan M, Grudzinskas JG. Timed unilateral follicular aspiration prior to administration of human chorionic gonadotropin for the prevention of severe ovarian hyperstimulation syndrome in in-vitro fertilization:a prospective randomized study. Hum Reprod 1997; 12:2603-2606. [DOI:10.1093/humrep/12.12.2603]
9. Aflatoonian A, Dehghani-Firouzabadi R, Kalantar SM, Solimani M, Karymzadeh-Mibodi MA, Taheripanah R, et al. The role of aspiration of half of ovarian follicles prior to administration of hCG or GnRH-a for prevention of severe OHSS in ART programs. Middle East Fertility Society Journal 2000; 5:73-75.
10. Queenan JTJr, Veeck LL, Toner JP, Oehninger S, Muasher SJ. Cryopreservation of all prezygotes in patients at risk of severe hyperstimulation does not eliminate the syndrome, but the chances of pregnancy are excellent with subsequent frozen-thaw transfers. Hum Reprod 1997; 12:1573-1576. [DOI:10.1093/humrep/12.7.1573]
11. Rabinovici J, Kushnir O, Shalev J, Goldenberg M, Blankstein J. Rescue of menotrophin cycles prone to develop ovarian hyperstimulation. Br J Obstet Gynecol 1987; 94:1098-1102. [DOI:10.1111/j.1471-0528.1987.tb02297.x]
12. Urman B, Pride SM, Yuen BH. Management of overstimulated gonadotrophin cycles with a controlled drift period. Hum Reprod 1992; 7:213-217. [DOI:10.1093/oxfordjournals.humrep.a137619]
13. Schenker JG .Prevention and treatment of ovarian hyperstimulation. Hum Reprod 1993; 8:653-659. [DOI:10.1093/oxfordjournals.humrep.a138115]
14. Ben-Nun I, Shulman A, Ghetler Y, Shilon M, Kaneti H , Beyth Y. The significance of 17 beta-estradiol levels in highly responding women during ovulation induction in IVF treatment: its impact and prognostic value with respect to oocyte maturation and treatment outcome. J Assist Reprod Genet 1993; 10:213-215. [DOI:10.1007/BF01239223]
15. Alvarez C, Bosch E, Melo MAB, Fernandez-Sanchez M, Munoz EA, Remohi J, et al. The dopamine agonist cabergoline prevents moderate-severe early ovarian hyperstimulation syndrome (OHSS) in high-risk patients. Hum Reprod 2006; 21: i96.
16. Tiitinen A, Husa LM, Tulppala M, Simberg N, Seppala M. The effect of cryopreservation in prevention of ovarian hyperstimulation syndrome. Br J Obstet Gynaecol 1995; 102:326-329. [DOI:10.1111/j.1471-0528.1995.tb09140.x]
17. Sher G, Salem R, Feinman M, Dodge S, Zouves C, Knutzen V. Eliminating the risk of life-endangering complications following overstimulation with menotropin fertility agents: a report on women undergoing in vitro fertilization and embryo transfer. Obstet Gynecol 1993; 81:1009-1011.
18. Aflatoonian A, Mahani IM, Tabibnejad N. Comparison of coasting with aspiration half of follicles before HCG injection for prevention of OHSS in ART cycles. Hum Reprod 2006; 21: s137.
19. Alvarez C, Gonzalez S, Crespo J, Simón C, Remohı́ J, Pellicer A. Cabergoline (Cb2) administration to prevent ovarian hyperstimulation syndrome (OHSS) in IVF ICSI does not reduce implantation and pregnancy rates. Fertil Steril 2006; 86: s337. [DOI:10.1016/j.fertnstert.2006.07.916]
20. Gomez R, Gonzalez M, Zimmermann R, Remohi J, Simon C , Pellicer A. Segregation of the antiapermeability and the antiangiogenic effects derived from VEGFR2 blockade by cabergoline. A specific non-toxic approach to treat OHSS. Fertil Steril 2006; 86: s45. [DOI:10.1016/j.fertnstert.2006.07.124]
21. Tortoriello DV, McGovern PG, Colon JM, Skurnick JH, Lipetz K, Santoro N. "Coasting" does not adversely affect cycle outcome in a subset of highly responsive in vitro fertilization patients. Fertil Steril 1998; 69: 454-460. [DOI:10.1016/S0015-0282(97)00560-8]
22. Enskog A, Henriksson M, Unander M, Nilsson L, Brännström M. Prospective study of the clinical and laboratory parameters of patients in whom ovarian hyperstimulation syndrome developed during controlled ovarian hyperstimulation for in vitro fertilization. Fertil Steril 1999; 71: 808-814. [DOI:10.1016/S0015-0282(99)00090-4]
23. Waldenstrom U, Kahn J, Marsk L, Nilsson S. High pregnancy rates and successful prevention of severe ovarian hyperstimulation syndrome by prolonged coasting of very hyperstimulated patients: a multicentre study. Hum Reprod 1999; 14:294-297. [DOI:10.1093/humrep/14.2.294]
24. Ulug U, Bahceci M, Erden HF, Shalev E, Ben-Shlomo. The significance of coasting duration during ovarian stimulation for conception in assisted fertilization cycles. Hum Reprod 2002; 17: 310-313. [DOI:10.1093/humrep/17.2.310]
25. Speroff L, Fritz MA. Induction of ovulation. In: Clinical Gynecologic Endocrinology and Infertility. Los Angeles. Lippincott Williams & Wilkins 2005: 1175-1214.
26. Crosignani PG. Management of hyperprolactiaemic infertility. In: Ovulation induction. Paris. ELSEVIER, 2002: 79-86.
Send email to the article author

Rights and permissions
Creative Commons License This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.

Designed & Developed by : Yektaweb